atomik labz retatrutide glp-3 (Reta GLP-3) - 99%+ Purity Buy Retatrutide (GLP-3R) | Research

Patients achieved substantial weight loss during the initial GLP-1 RA phase (~1822% at 12 months), which was subsequently maintained after its discontinuation, with total weight reduction reaching 25.5% (95% CI 23.127.9%) at 593 days, with most patients on metformin

The Clinical Evidence Behind B420 The core clinical data for B420 comes from a 6-month randomized, placebo-controlled trial (Stenman et al., *EBioMedicine* 2016, N=225)

FDA Submission Timeline The NDA timeline and TRIUMPH milestones feeding into FDA review

It remains an investigational medicinal product (IMP) and is therefore not available for prescription or purchase in the United Kingdom outside of approved clinical trials

Omada, which supports diabetes, obesity, hypertension and musculoskeletal conditions, launched its GLP-1 Care Track in 2023 in response to client requests